NCT02214550View on ClinicalTrials.gov

Chronic Pain Risk Associated With Menstrual Period Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

353

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

November 30, 2020

Study Completion Date

January 31, 2021

Conditions
Cystitis, InterstitialDysmenorrheaMigraine DisordersPelvic PainEndometriosisVisceral PainChronic Pain
Interventions
DRUG

cyclic microgestin 1/20

Cyclic OC Use - Participants will ingest pills containing active hormones for 21 days followed by 7 days of no pills, and then the cycle will repeat

DRUG

continuous microgestin 1/20

Continuous OC use - Pills containing hormones will be taken every day for 1 year

Trial Locations (1)

60201

NorthShore University Health System, Evanston

Sponsors

Lead Sponsor

Endeavor Health
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Endeavor Health

OTHER